Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.
Oomen I, Verhagen M, Miranda M, Allacher P, Beckers EAM, Blijlevens NMA, van der Bom JG, Coppens M, Driessens M, Eikenboom JCJ, Fijnvandraat K, Hassan S, van Heerde WL, Hooimeijer HL, Jansen JH, Kaijen P, Leebeek FWG, Meijer D, Paul H, Rijpma SR, Rosendaal FR, Smit C, van Vulpen LFD, Voorberg J, Schols SEM, Gouw SC. Oomen I, et al. Among authors: van heerde wl. Front Immunol. 2024 Feb 22;15:1355813. doi: 10.3389/fimmu.2024.1355813. eCollection 2024. Front Immunol. 2024. PMID: 38455035 Free PMC article.
The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A.
Valke LLFG, Verhagen MJA, Mulders BTPM, Polenewen R, Blijlevens NMA, Jansen JH, Mansouritorghabeh H, Elsheikh E, Reipert BM, Turecek PL, O'Donnell JS, Rijpma SR, Schols SEM, van Heerde WL, Meijer D. Valke LLFG, et al. Among authors: van heerde wl. Thromb Res. 2023 Nov;231:112-120. doi: 10.1016/j.thromres.2023.10.007. Epub 2023 Oct 11. Thromb Res. 2023. PMID: 37844518
Pharmacokinetic-Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate.
Valke LLFG, Cloesmeijer ME, Mansouritorghabeh H, Barteling W, Blijlevens NMA, Cnossen MH, Mathôt RAA, Schols SEM, van Heerde WL. Valke LLFG, et al. Among authors: van heerde wl. Eur J Drug Metab Pharmacokinet. 2024 Mar;49(2):191-205. doi: 10.1007/s13318-024-00876-6. Epub 2024 Feb 17. Eur J Drug Metab Pharmacokinet. 2024. PMID: 38367175 Free PMC article.
Inhibitor development and mortality in non-severe hemophilia A.
Eckhardt CL, Loomans JI, van Velzen AS, Peters M, Mauser-Bunschoten EP, Schwaab R, Mazzucconi MG, Tagliaferri A, Siegmund B, Reitter-Pfoertner SE, van der Bom JG, Fijnvandraat K; INSIGHT Study Group. Eckhardt CL, et al. J Thromb Haemost. 2015 Jul;13(7):1217-25. doi: 10.1111/jth.12990. Epub 2015 Jun 10. J Thromb Haemost. 2015. PMID: 25912309 Free article.
High prevalence of heavy menstrual bleeding in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study.
Maas DPMSM, Saes JL, Blijlevens NMA, Cnossen MH, den Exter PL, van der Heijden OWH, Kruis IC, Meijer K, Peters M, Schutgens REG, van Heerde WL, Nieuwenhuizen L, Schols SEM; RBiN study group. Maas DPMSM, et al. Among authors: van heerde wl. J Thromb Haemost. 2023 Oct;21(10):2726-2734. doi: 10.1016/j.jtha.2023.07.014. Epub 2023 Jul 29. J Thromb Haemost. 2023. PMID: 37517479 Free article.
Solid-Phase Synthesis of Caged Luminescent Peptides via Side Chain Anchoring.
Sondag D, Heming JJA, Löwik DWPM, Krivosheeva E, Lejeune D, van Geffen M, Van't Veer C, van Heerde WL, Beens MCJ, Kuijpers BHM, Boltje TJ, Rutjes FPJT. Sondag D, et al. Among authors: van heerde wl. Bioconjug Chem. 2023 Dec 20;34(12):2234-2242. doi: 10.1021/acs.bioconjchem.3c00381. Epub 2023 Dec 6. Bioconjug Chem. 2023. PMID: 38055970 Free PMC article.
Synthesis and Evaluation of Glycosyl Luciferins.
Sondag D, de Kleijne FFJ, Castermans S, Chatzakis I, van Geffen M, Van't Veer C, van Heerde WL, Boltje TJ, Rutjes FPJT. Sondag D, et al. Among authors: van heerde wl. Chemistry. 2024 Jan 11;30(3):e202302547. doi: 10.1002/chem.202302547. Epub 2023 Nov 27. Chemistry. 2024. PMID: 37849395
In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype.
Verhagen MJA, van Heerde WL, van der Bom JG, Beckers EAM, Blijlevens NMA, Coppens M, Gouw SC, Jansen JH, Leebeek FWG, van Vulpen LFD, Meijer D, Schols SEM. Verhagen MJA, et al. Among authors: van heerde wl. Res Pract Thromb Haemost. 2023 Feb 1;7(2):100062. doi: 10.1016/j.rpth.2023.100062. eCollection 2023 Feb. Res Pract Thromb Haemost. 2023. PMID: 36865907 Free PMC article.
High prevalence of postpartum hemorrhage in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study.
Maas DPMSM, Saes JL, Blijlevens NMA, Cnossen MH, den Exter PL, van der Heijden OWH, Kruis IC, Meijer K, Peters M, Schutgens REG, van Heerde WL, Nieuwenhuizen L, Schols SEM; RBiN study group. Maas DPMSM, et al. Among authors: van heerde wl. J Thromb Haemost. 2023 Mar;21(3):499-512. doi: 10.1016/j.jtha.2022.11.009. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696205 Free article.
86 results